Aktiesnakken — Januar 2010
-
Hun er som en metronom der afstemmer forventningerne med markedet. Så fintfølende. Er det et højt A.....så svinger lisa lige stemmegaflen
-
Lisa gejle markedet op. Never......utænkeligt...
-
En af de stærke cornichoner.....
-
Hej. Arzerra er godkendt som 3rd line beh. af senfase CLL patienter, altså terminale pt
-
I kender vel allerede hjemmesiden http://www.clltopics.org/ ??
-
ok
-
Det kommer selvfølgelig hen ad vejen, men tror nu mere at det bliver fra mindre syge pt. der får det offlabel i stedet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind